Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion type Assertion NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_head.
- NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion description "[Thus far, the human epidermal growth factor receptor (HER) pathway, angiogenic pathway, and phosphatidylinositol-3-kinase (PI3K)-Akt-mammalian target of rapamycin pathway have emerged as potential avenues for targeted therapy in AGC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_provenance.
- NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion evidence source_evidence_literature NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_provenance.
- NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion SIO_000772 22334453 NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_provenance.
- NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion wasDerivedFrom befree-20150227 NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_provenance.
- NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_assertion wasGeneratedBy ECO_0000203 NP412229.RA8qUmLHe1SUysPumWBv69Q6IoVkG-qiL0HpZzQheu5_c130_provenance.